Tissue quality
Improve structural integrity, vascularization, and long-term function of printed tissues.
Track 3
3D print organs
Organ failure is a hard boundary for lifespan. This track removes donor scarcity by scaling bioprinted tissue and organ replacement pathways.
What needs to improve
Production scale
Move from bespoke research workflows to repeatable manufacturing-grade organ production lines.
Clinical integration
Standardize implantation, monitoring, and maintenance protocols for printed organs in hospitals.
Possible milestones
Research goals, not forecasts or a promised timeline.
Step 1
Advanced tissue grafts mature
Reliable printed tissues handle partial-replacement and repair use cases.
Step 2
Complex organ prototypes deploy
Higher-function organ systems move through tightly monitored clinical pathways.
Step 3
Personalized replacement scales
On-demand patient-specific organ replacement reduces late-life failure bottlenecks.
Main risks
- Vascular complexity and long-term viability of printed organs.
- Quality control and sterility at manufacturing scale.
- High cost and uneven deployment across healthcare systems.